124 related articles for article (PubMed ID: 6282800)
1. The effect of inhibitors of beta-lactamases on beta-lactamase extracts and on intact cells.
Li JT; Moosdeen F; Williams JD
J Antimicrob Chemother; 1982 Apr; 9(4):287-96. PubMed ID: 6282800
[No Abstract] [Full Text] [Related]
2. 6-beta-bromo- and 6-beta-iodo penicillanic acid, two novel beta-lactamase inhibitors.
Wise R; Andrews JM; Patel N
J Antimicrob Chemother; 1981 May; 7(5):531-6. PubMed ID: 6267005
[No Abstract] [Full Text] [Related]
3. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
Neu HC; Fu KP
Antimicrob Agents Chemother; 1980 Oct; 18(4):582-5. PubMed ID: 6255862
[TBL] [Abstract][Full Text] [Related]
4. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.
Wise R; Andrews JM; Bedford KA
J Antimicrob Chemother; 1980 Mar; 6(2):197-206. PubMed ID: 6247316
[No Abstract] [Full Text] [Related]
5. Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.
Easton CJ; Knowles JR
Antimicrob Agents Chemother; 1984 Sep; 26(3):358-63. PubMed ID: 6095753
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Fu KP; Neu HC
J Antimicrob Chemother; 1981 Mar; 7(3):287-92. PubMed ID: 6268598
[No Abstract] [Full Text] [Related]
7. Evolution of beta-lactamase inhibitors.
Rolinson GN
Rev Infect Dis; 1991; 13 Suppl 9():S727-32. PubMed ID: 1656513
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactamase inactivation by mechanism-based reagents.
Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR
Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326
[TBL] [Abstract][Full Text] [Related]
9. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
Chin NX; McElrath MJ; Neu HC
Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
[TBL] [Abstract][Full Text] [Related]
10. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
Grace ME; Fu KP; Gregory FJ; Hung PP
Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
[TBL] [Abstract][Full Text] [Related]
11. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
Cullmann W; Binder S; Stieglitz M
Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
[TBL] [Abstract][Full Text] [Related]
12. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
Nord CE
J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
[No Abstract] [Full Text] [Related]
13. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
Campos M; Alarcón MA; González H; Sánchez R
Microbios; 1993; 76(308):171-9. PubMed ID: 8302198
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
Sorg TB; Cynamon MH
J Antimicrob Chemother; 1987 Jan; 19(1):59-64. PubMed ID: 3030999
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
16. Microbiological properties of sulbactam combined with ampicillin.
Barba D; Galante D; Esposito S; Ruffilli MP
Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
Neu HC
Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
Qadri SM; Ueno Y; Cunha BA
Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
[TBL] [Abstract][Full Text] [Related]
19. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
Aldridge KE; Sanders CV; Marier RL
J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
Chao HP; Ho SW; Luh KT; Hsieh WC
Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
[No Abstract] [Full Text] [Related]
[Next] [New Search]